Ignite Creation Date:
2025-12-24 @ 4:59 PM
Ignite Modification Date:
2026-01-01 @ 6:30 PM
Study NCT ID:
NCT00256750
Status:
COMPLETED
Last Update Posted:
2016-08-19
First Post:
2005-11-15
Is NOT Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
Belatacept Evaluation of Nephroprotection and Efficacy as First-line Immunosuppression (BENEFIT)
Sponsor:
Bristol-Myers Squibb
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2005-03
Start Date Type:
None
Primary Completion Date:
2008-06
Primary Completion Date Type:
ACTUAL
Completion Date:
2015-04
Completion Date Type:
ACTUAL
First Submit Date:
2005-11-15
First Submit QC Date:
None
Study First Post Date:
2005-11-22
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
2016-05-24
Results First Submit QC Date:
None
Results First Post Date:
2016-08-19
Results First Post Date Type:
ESTIMATED
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
2010-05-03
Disp First Post Date Type:
ESTIMATED
Last Update Submit Date:
2016-07-12
Last Update Post Date:
2016-08-19
Last Update Post Date Type:
ESTIMATED